PureTech Health (LON:PRTC - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Jefferies Financial Group in a report released on Monday, MarketBeat Ratings reports. They presently have a GBX 455 ($5.77) price target on the stock. Jefferies Financial Group's price target suggests a potential upside of 167.65% from the stock's current price.
PureTech Health Price Performance
PureTech Health stock traded up GBX 7.20 ($0.09) during trading hours on Monday, hitting GBX 170 ($2.16). 2,001,059 shares of the company traded hands, compared to its average volume of 579,760. The firm's 50-day simple moving average is GBX 161.22 and its two-hundred day simple moving average is GBX 171. The firm has a market cap of £407.01 million, a P/E ratio of -739.13 and a beta of 1.02. PureTech Health has a 1-year low of GBX 138.75 ($1.76) and a 1-year high of GBX 238.50 ($3.03). The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 47.27.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
